Adenosine–deaminase–deficient mice die perinatally and exhibit liver–cell degeneration, atelectasis and small intestinal cell death (original) (raw)

References

1. Chinsky, J.M. et al. Developmental expression of adenosine deaminase in the upper alimentary tract of mice. Differentiation 42, 172–183 (1990).
   Article CAS Google Scholar
2. Ramamurthy, V. et al. Prenatal and postnatal expression of adenosine deaminase in mice. in Molecular and cellular mechanisms of human hypersensitivity and autoimmunity. (ed. Goetzl, E.J.) 125–131 (Liss, New York, 1989).
   Google Scholar
3. Aronow, B. et al. Evidence for a complex regulatory array in the first intron of the human adenosine deaminase gene. Genes Dev. 3, 1384–1400 (1989).
   Article CAS Google Scholar
4. Witte, D.P., Wiginton, D.A., Hutton, J.J. & Aronow, B.J. Coordinate developmental regulation of purine catabolic enzyme expression in gastrointestinal and postimplantation reproductive tracts. J. Cell Biol. 115, 179–190 (1991).
   Article CAS Google Scholar
5. Hirschhorn, R. Adenosine deaminase deficiency. in Immunodeficiency Reviews (ed. Rosen, F.S. & Seligmann, M.) 175–198 (Harwood Academic, New York, 1990).
   Google Scholar
6. Giblett, E.R., Anderson, J.E., Cohen, F., Pollara, B. & Meuwissen, H.J. Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet II, 1067–1069 (1972).
   Article Google Scholar
7. Hershfield, M.S. & Mitchell, B.S. Immunodeficiency diseases caused by adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency. in The Molecular and Metabolic Basis of Inherited Disease (ed. Scriver, C.R., Beaudet, A.L, Sly, W.S. & Valle, D.) 1725–1768 (McGraw-Hill, New York, 1994).
   Google Scholar
8. Ratech, H. et al. Pathologic findings in adenosine-deaminase-deficient severe combined immunodeficiency I. Kidney, adrenal gland, and chondro-osseous tissue alterations. Am. J. Pathol. 120, 157–169 (1985a).
   CAS PubMed PubMed Central Google Scholar
9. Ratech, H., Hirschhorn, R. & Greco, A. Pathologic findings in adenosine deaminase-severe combined immunodeficiency II. Thymus, spleen, Lymph node, and gastrointestinal tract lymphoid tissue alterations. Am. J. Pathol. 135, 1145–1156 (1989).
   CAS PubMed PubMed Central Google Scholar
10. Hoogerbrugge, P., van Beusechem, V.W., Kaptein, L.C.M., Einerhand, M.P.W. & Valerio, D. Gene therapy for adenosine deaminase deficiency. Brit. med. Bull. 51, 72–61 (1995).
    Article CAS Google Scholar
11. Cohen, A., Hirschhorn, R., Horowitz, S.D., Rubinstein, A. & Polmar, S.H. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Proc. natn. Acad. Sci. U.S.A. 75, 472–476 (1978).
    Article CAS Google Scholar
12. Coleman, M.S. et al. Identification and quantitation of adeninedeoxynucleotides in erythrocytes of a patient with adenosine deaminase deficiency and severe immunodeficiency. J. biol. Chem. 253, 1619–1626 (1978).
    CAS PubMed Google Scholar
13. Ullman, B., Gudas, L.J., Cohen, A. & Martin, D.W.J. Deoxyadenosin metabolism and cytotoxicity in cultured mouse lymphoma cells A model for immunodeficiency disease. Cell 14, 365–375 (1978).
    Article CAS Google Scholar
14. Seto, S., Carrera, C.J., Kubota, M., Wasson, D.B. & Carson, D.A. Mechanism of deoxyadenosine and 2-chlorodeoxyadenosine toxicity to nondividing human lymphocytes. J. Clin. Invest. 75, 377–383 (1985).
    Article CAS Google Scholar
15. Kizaki, H., Shimada, H., Ohsaka, F., Sakurada, T. Adenosine, deoxyadenosine, and deoxyguanosine induce DNAcleavage in mouse thymocytes. J. Immunol. 141, 1652–1657 (1988).
    CAS PubMed Google Scholar
16. Kredich, M.W. & Martin, D.W.J. Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T-lymphoma cells. Cell 12, 931–938 (1977).
    Article CAS Google Scholar
17. Hershfield, M.S. Apparent suicide inactivation of human lymphoblast S-adenosyl-homocysteine hydrolase by 2′-deoxyadenosine and adenine arabinoside. J. biol. Chem. 254, 22–25 (1979b).
    CAS PubMed Google Scholar
18. Hershfield, M.S., Kredich, N.M., Ownby, D.R., Ownby, H. & Buckley, R. In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2′-deoxyadenosine in adenosine deaminase-deficient patients. J. Clin. Invest. 63, 807–811 (1979a).
    Article CAS Google Scholar
19. Kredich, N.M., Hershfield, M.S. & Johnston, J.M. Role of methylation in adenosine toxicity in adenosine deaminase inhibited cells. in Inborn Errors of Specific Immunity. (ed. Pollara, B., Pickering, J., Meuwissen, H.J. & Porter, I.H.) 261–268 (Academic Press, New York, 1979).
    Google Scholar
20. Hershfield, M.S. & Kredich, N.M. Resistance of an adenosine kinase-deficient human lymphoblastoid cell line to effects of deoxyadenosine on growth, S-adenosylhomocysteine hydrolase inactivation, and dATP accumulation. Proc. natn. Acad. Sci. U.S.A. 77, 4292–4296 (1980).
    Article CAS Google Scholar
21. Greenberg, M.L., Chaffee, S. & Hershfield, M.S. Basis for resistance to 3-deazaaristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase, in human B-lymphoblasts. J. biol. Chem. 264, 795–803 (1989).
    CAS PubMed Google Scholar
22. Wolos, J.A. et al. Selective inhibition of T-cell activation by an inhibitor of S-adenosyl-L-homocysteine hydrolase. J. Immunol. 150, 3264–3273 (1993).
    CAS PubMed Google Scholar
23. Hirschhorn, R. Overview of biochemical abnormalities and molecular genetics of adenosine deaminase deficiency. Ped. Res. 33, s35–s41 (1993).
    Article CAS Google Scholar
24. Santisteban, I. et al. Novel splicing, missense and deletion mutations in 7 adenosine deaminase deficient patients with late/delayed onset of combined immunodeficiency disease: contribution of genotype to phenotype. J. Clin. Invest. 92, 2291–2302 (1993).
    Article CAS Google Scholar
25. Shovlin, C.L. et al. Adult onset immunodeficiency caused by inherited adenosine deaminase deficiency. J. Immunol. 153, 2331–2339 (1994).
    CAS PubMed Google Scholar
26. teRiele, H., Robanus-Maandag, E. & Berns, A. Highly efficient gene targeting in embryonic stem cells through homologous recombination with isogenic DNA constructs. Proc. natn. Acad. Sci. U.S.A. 89, 5128–5132 (1992).
    Article CAS Google Scholar
27. Wilson, O.K., Rudolph, F.B. & Quiocho, F.A. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science 252, 1278–1284 (1991).
    Article CAS Google Scholar
28. Akeson, A.L., Winginton, D.A., Dusing, M.R., States, J.C. & Hutton, J.J. Mutant human adenosine deaminase alleles and their expression by transfection into fibroblasts. J. biol. Chem. 263, 16291–16296 (1988).
    CAS PubMed Google Scholar
29. Linch, D.C., Levinsky, R.J., Rodeck, C.H., Maclennan, K.A. & Simmonds, H.A. Prenatal diagnosis of three casesof severe combined immunodeficiency: severe T cell deficiency during the first half of gestation in fetuses with adenosine deaminase deficiency. Clin. exp. Immunol. 56, 223–232 (1984).
    CAS PubMed PubMed Central Google Scholar
30. Fowlkes, B.J. & Pardoll, D.M. Molecular and cellular events in T cell development. Adv. Immunol. 44, 207–264 (1989).
    Article CAS Google Scholar
31. Ratech, H., Hirschhorn, R. & Thorbecke, G.J. Effects of deoxycoformycin in mice III. A murine model reproducing the multi-system pathology of human adenosine deaminase deficiency. Am. J. Path. 119, 65–72 (1985).
    CAS PubMed Google Scholar
32. Tedde, A. et al. Animal model for immune dysfunction associated with adenosine deaminase deficiency. Proc. natn. Acad. Sci. U.S.A. 77, 4899–4903 (1980).
    Article CAS Google Scholar
33. Hershfield, M.S. et al. S-adenosylhomocysteine hydrolase catabolism and basis for acquired resistance during treatment of T-cell acute lymphoblastic leukemia with 2′-deoxycoformycin alone and in combination with 9-β-D-arabinofuranosyladenine. Cancer Res. 43, 3451–3458 (1983).
    CAS PubMed Google Scholar
34. Hershfield, M.S. et al. Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2′-deoxycoformycin. Proc. natn. Acad. Sci. U.S.A. 81, 253–257 (1984).
    Article CAS Google Scholar
35. Carson, D.A., Kaye, J. & Wasson, D.B. Differences in deoxyadenosine metabolism in human and mouse lymphocytes. J. Immunol. 124, 8–12 (1980).
    CAS PubMed Google Scholar
36. Hershfield, M.S. et al. Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM cells. J. biol. Chem. 257, 6380–6386 (1982).
    CAS PubMed Google Scholar
37. Ullman, B., Levinson, B.B., Hershfield, M.S. & Martin, D.W.J. A biochemical genetic study of the role of specific nucleoside kinases in deoxyadenosine phosphorylation by cultured human cells. J. biol. Chem. 256, 848–852 (1981).
    CAS PubMed Google Scholar
38. Karlsson, A., Johansson, M. & Eriksson, S. Cloning and expression of mouse deoxycytidine kinase; pure recombinant mouse and human enzymes show differences in substrate specificity. J. biol. Chem. (1994).
39. Gao, X., Blackburn, M.R. & Knudsen, T.B. Activation of apoptosis in early mouse embryos by 2′-deoxyadenosine exposure. Teratology 49, 1–12 (1994).
    Article CAS Google Scholar
40. Surh, C.D. & Sprent, J. T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372, 100–103 (1994).
    Article CAS Google Scholar
41. Hirschhorn, R., Roegner, V., Rubinstein, A. & Papageorgiou, P. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child. J. Clin. Invest. 65, 768–771 (1980).
    Article CAS Google Scholar
42. Olsson, R.A. & Pearson, J.D., 70, 761–845 (1990).
43. Bontemps, F., Vincent, M.F. & van den Berghe, G. Mechanisms of elevation of adenosine levels in anoxic hepatocytes. Biochem. J. 290, 671–677 (1993).
    Article CAS Google Scholar
44. Helland, S. & Ueland, P.M. Effect of 2′-deoxycoformycin infusion on S-adenosylhomocysteine hydrolase and the amount of S-adenosylhomocysteine and related compounds in tissues of mice. Cancer Res. 43, 4142–4147 (1983).
    CAS PubMed Google Scholar
45. Wainfan, E. & Poirier, L.A. Methyl groups in carcinogenesis: effects on DNA methylation and gene expression. Cancer Res. 52, 2071s–2077s (1992).
    CAS PubMed Google Scholar
46. Miller, M.W. et al. The mouse lethal nonagouti (ax) mutation deletes the S-adenosylhomocysteine hydrolase (Ahcy) gene. EMBO J. 13, 1806–1816 (1994).
    Article CAS Google Scholar
47. Markert, M.L., Hutton, J.J., Wiginton, D.A., States, J.C. & Kaufman, R.E. Adenosine deaminase (ADA) deficiency due to deletion of the ADA gene promoter and first exon by homologous recombination between two Alu elements. J. Clin. Invest. 81, 1323–1327 (1988).
    Article CAS Google Scholar
48. Berkvens, T.M., van Ormondt, H., Gerritsen, E.J.A., Meera Khan, P. & van der Eb, A.J. Identical 3250-bp deletion between two Alul repeats in the ADA genes of unrelated ADA-SCID patients. Genomics 7, 486–490 (1990).
    Article CAS Google Scholar
49. Grosveld, F.G., Lund, T., Mellor, A.L. & Flavell, R.A. The construction of cosmid libraries which can be used to transform eukaryotic cells. Nucl. Acids Res. 10, 6715–6732 (1982).
    Article CAS Google Scholar
50. te Riele, H., Robanus-Maandag, E., Clarke, A., Hooper, M. & Berns, A. Consecutive inactivation of both alleles of the pim-1 proto-oncogene by homologous recombination in embryonic stem cells. Nature 348, 649–651 (1990).
    Article CAS Google Scholar
51. Hooper, M., Friedmann, M., Reeves, R. & Magnuson, N.S. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germ line colonization by cultured cells. Nature 326, 292–295 (1987).
    Article CAS Google Scholar
52. Smith, A.G. & Hooper, M.L. Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Devl. Biol. 121, 1–9 (1987).
    Article CAS Google Scholar
53. Abbondanzo, S.J., Gadi, I. & Stewart, C.L. Derivation of embryonic stem cell lines. in Methods in Enzymology, Guide to techniques in mouse development (eds Wassarman, P. M. & De Pamphilis, M.L.) 803–822 (Academic Press, San Diego, 1993).
    Chapter Google Scholar
54. Stewart, C.L. Production of chimeras between embryonic stem cells and embryos. in Methods in Enzymology, Guide to techniques in mouse development (eds Wassarman, P. M. & De Pamphilis, M.L) 823–854 (Academic Press, San Diego, 1993).
    Chapter Google Scholar
55. Laird, P.W. et al. Simplified mammalian DNA isolation procedure. Nucl. Acids Res. 19, 4293–4295 (1991).
    Article CAS Google Scholar
56. Maniatis, T., Fritsch, E.F. & Sambrook, J. Molecular cloning: a laboratory manual (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1982).
57. Meera Khan, P. Enzyme electrophoresis on cellulose acetate gel: zymogram patterns in man-mouse and man-chinese hamster somatic cell hybrids. Arch. Biochem. Biophys. 145, 470–483 (1971).
    Article CAS Google Scholar
58. Buchou, T. et al. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines. Oncogene. 8, 1765–1773 (1993).
    CAS PubMed Google Scholar
59. Arredondo-Vega, F.X. et al. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combined immunodeficiency. J. Clin. Invest. 86, 444–452 (1990).
    Article CAS Google Scholar
60. Hershfield, M.S., Aiyar, V.N., Premakumar, R. & Small, W.C. S-adenosyl homocysteine hydrolase from human placenta. Biochem. J. 230, 43–52 (1985).
    Article CAS Google Scholar
61. Ossendorp, F. et al. T cell receptor-ab lacking the b-chain V domain can be expressed at the cell surface but prohibits T cell maturation. J. Immunol. 148, 3714–3722 (1992).
    CAS PubMed Google Scholar

Download references